These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 2858584)

  • 1. Comparison of the cardiovascular actions of dopamine and epinine in the dog.
    Itoh H; Kohli JD; Rajfer SI; Goldberg LI
    J Pharmacol Exp Ther; 1985 Apr; 233(1):87-93. PubMed ID: 2858584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
    Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
    J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the alpha adrenoceptor activity of dopamine, ibopamine and epinine in the pulmonary circulation of the dog.
    Shebuski RJ; Fujita T; Smith JM; Ruffolo RR
    J Pharmacol Exp Ther; 1987 Apr; 241(1):6-12. PubMed ID: 3033210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the alpha and beta adrenoceptor-mediated activities of the novel, orally active inotropic agent, ibopamine, in the cardiovascular system of the pithed rat: comparison with epinine and dopamine.
    Nichols AJ; Ruffolo RR
    J Pharmacol Exp Ther; 1987 Aug; 242(2):455-63. PubMed ID: 3039117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consistent unmasking of dopamine-induced dilation of the canine femoral vascular bed.
    Listinsky JJ; Kohli JD; Goldberg LI
    J Pharmacol Exp Ther; 1980 Dec; 215(3):662-7. PubMed ID: 6108364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dog.
    Kopia GA; Ohlstein EH; Ruffolo RR
    J Pharmacol Exp Ther; 1988 Aug; 246(2):434-40. PubMed ID: 3404441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent separation of dopaminergic and adrenergic effects of epinine in healthy volunteers.
    Daul A; Elter-Schulz M; Poller U; Jockenhövel F; Pönicke K; Boomsma F; Man in't Veld AJ; Schäfes RF; Brodde OE
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):429-37. PubMed ID: 8532072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cerebroventricular administration of ouabain on renal hemodynamics in anesthetized dogs: evidence for the participation of renal dopaminergic vasodilator fibers.
    Hom GJ; Jandhyala BS
    J Pharmacol Exp Ther; 1984 Aug; 230(2):275-83. PubMed ID: 6747837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ibopamine on diuresis and arterial blood pressure in anesthetized rats and its interactions with dopaminergic and alpha- and beta-adrenergic antagonists.
    Ferrini R; Miragoli G
    Arzneimittelforschung; 1986 Feb; 36(2A):323-6. PubMed ID: 2871844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ring fluorination on the cardiovascular actions of dopamine and norepinephrine in the dog.
    Goldberg LI; Kohli JD; Cantacuzene D; Kirk KL; Creveling CR
    J Pharmacol Exp Ther; 1980 Jun; 213(3):509-13. PubMed ID: 6894165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N,N-Di-n-propyl dopamine: a qualitatively different dopamine vascular agonist.
    Kohli JD; Goldberg LI; Volkman PH; Cannon JG
    J Pharmacol Exp Ther; 1978 Oct; 207(1):16-22. PubMed ID: 702336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential cardiovascular and neuroendocrine effects of epinine and dopamine in conscious pigs before and after adrenoceptor blockade.
    van Woerkens LJ; Boomsma F; Man in 't Veld AJ; Bevers MM; Verdouw PD
    Br J Pharmacol; 1992 Oct; 107(2):303-10. PubMed ID: 1330172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined effects of dopamine (DA) and the DA antagonists EGYT-2509, chlorpromazine and haloperidol on the kidney function.
    Kövér G; Fekete M; Tost H; Szemerédi K
    Acta Physiol Hung; 1988; 72(3-4):321-33. PubMed ID: 3250211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of epinine on arterial blood pressure and regional vascular resistances in anesthetized rats.
    Martínez-Mir I; Palop V; Morales-Olivas FJ; Estañ L; Rubio E
    Gen Pharmacol; 1998 Jul; 31(1):75-9. PubMed ID: 9595283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic hemodynamic and regional blood flow effects of LY141865, a selective dopamine receptor agonist.
    Hahn RA; MacDonald BR
    J Pharmacol Exp Ther; 1984 Sep; 230(3):558-68. PubMed ID: 6470973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cardiovascular actions of dopamine and the effects of central and peripheral catecholaminergic receptor blocking drugs.
    Setler PE; Pendleton RG; Finlay E
    J Pharmacol Exp Ther; 1975 Mar; 192(3):702-12. PubMed ID: 1120964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alpha adrenoceptor and dopamine receptor agonists and antagonists on ganglionic transmission.
    Satoh Y; Kohli JD; Goldberg LI
    J Pharmacol Exp Ther; 1989 Oct; 251(1):253-7. PubMed ID: 2571718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dopamine, ibopamine, and epinine on alpha- and beta-adrenoceptors in canine pulmonary circulation.
    Shebuski RJ; Smith JM; Ruffolo R
    Fundam Clin Pharmacol; 1989; 3(3):211-21. PubMed ID: 2548941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.